Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity
Guangchuan Wang(Shandong University), Sidi Chen(Yale Cancer Center), Xiaoyun Dai(Yale Cancer Center), Lvyun Zhu(Yale Cancer Center), Lupeng Ye(Zhejiang University), Ryan D. Chow(Yale University), Charles S. Fuchs(Yale Cancer Center), Zhigang Bai(Yale Cancer Center), Jonathan J. Park(Yale Cancer Center), Matthew B. Dong(Yale University), Hanghui Ye(Yale University), Xiaoya Zhang(University of Wisconsin–Madison), Youssef Errami(Yale Cancer Center), Li Shen(Second Affiliated Hospital of Zhejiang University), Paul Renauer(Yale Cancer Center)
Cited by 121
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
|JAMA Oncology|2018|1.8k